The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Tadafil 2.5 mg Film-coated Tablets

2.5 milligram(s) Film-coated tablet

Medreich PlcPA22576/005/001

Main Information

Trade NameTadafil 2.5 mg Film-coated Tablets
Active SubstancesTadalafil
Strength2.5 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderMedreich Plc
Licence NumberPA22576/005/001

Group Information

ATC CodeG04BE08 tadalafil


Licence Issued29/11/2019
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back